A statement from the President on COVID-19

Common Statement: Supporting Statement for the Council… 14 June 2023 As trade associations representing off-patent medicines and Active Pharmaceutical Ingredients…
EMA/HMA share definitive EU-wide position on biosimilar… 19 September 2022 The Biosimilar medicines group, a Medicines for Europe sector group,…
Joint statement Association for Accessible Medicines -… 26 January 2024 Medicines for Europe and its members are strongly concerned by…
Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…